Berberine suppressed HCC, which was dependent on the binding of PPARδ to the promoters of apoptotic genes such as caspase 3, B-Cell CLL/Lymphoma 2 (BCL2) associated X protein (BAX), and BCL2. The gene discussed is CASP3; the disease is hepatocellular carcinoma.